Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | Director | May 21, 2026 | May 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date May 21, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,770 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 5,626 · Balance 36,770 F1: These shares vest 100% one year from grant award date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares vest 100% one year from grant award date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 22, 2026 17:36 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001755126-26-000002 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,770 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 15, 2025 Filed May 19, 2025 18:36 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-003981 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,144 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 16, 2024 Filed May 17, 2024 18:21 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 3,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004134 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,205 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 13:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionNon-Employee Director Stock Option Grant · Derivative | 4,430 | $21.46 Strike: $21.46 | $95,067.80 |
DisclosureSEC source: 0001562180-23-006083 · primarydocument.xml · derivative · entry 3 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,430 shares Expires 2028-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 13:05 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,430 | $33.20 | $147,094.16 |
DisclosureSEC source: 0001562180-23-006083 · primarydocument.xml · nonDerivative · entry 2 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,441 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.20 to $33.215. The price reported above reflects the weighted average price. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 13:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,430 | $21.46 | $95,067.80 |
DisclosureSEC source: 0001562180-23-006083 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2023 Filed May 22, 2023 13:37 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004340 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,441 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 19, 2022 Filed May 23, 2022 18:03 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 3,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004329 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,706 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 19, 2022 Filed May 26, 2022 18:06 UTC Amendment | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004421 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,725 F1 · shares: This Form 4 amendment is to correct an administrative error in column 4 and 5 of the Form 4 filed on May 23, 2022, which resulted in the number of restricted stock award reported as acquired by the reporting person being understated in the original filing. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:16 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 2,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003700 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,309 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:17 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003902 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,464 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| May 16, 2019 Filed May 20, 2019 11:46 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 4,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-002983 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,403 F1 · shares: These shares vest 100% one year from grant award date. Read SEC document |
| October 22, 2018 Filed Oct 22, 2018 21:12 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 1,000 | $20.41 | $20,406.00 |
DisclosureSEC source: 0001562180-18-004260 · primarydocument.xml · nonDerivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| September 28, 2018 Filed Oct 3, 2018 22:03 UTC | GENTEX CORP GNTX · Entity 3954 | GrantNon-Employee Director Stock Option Grant · Derivative | 4,430 | $21.46 Strike: $21.46 | $95,067.80 |
DisclosureSEC source: 0001562180-18-004157 · primarydocument.xml · derivative · entry 1 Starkoff Kathleen · CIK 0001755126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,430 Underlying: Common Stock · 4,430 shares Expires 2028-09-28 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.